[go: up one dir, main page]

CA2812705C - Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine - Google Patents

Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine Download PDF

Info

Publication number
CA2812705C
CA2812705C CA2812705A CA2812705A CA2812705C CA 2812705 C CA2812705 C CA 2812705C CA 2812705 A CA2812705 A CA 2812705A CA 2812705 A CA2812705 A CA 2812705A CA 2812705 C CA2812705 C CA 2812705C
Authority
CA
Canada
Prior art keywords
besylate
maleate
zopiclone
salt
eszopiclone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2812705A
Other languages
English (en)
Other versions
CA2812705A1 (fr
Inventor
H. Scott Wilkinson
Richard Hsia
Tushar Misra
Kostas Saranteas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Sunovion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunovion Pharmaceuticals Inc filed Critical Sunovion Pharmaceuticals Inc
Publication of CA2812705A1 publication Critical patent/CA2812705A1/fr
Application granted granted Critical
Publication of CA2812705C publication Critical patent/CA2812705C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2812705A 2007-12-19 2008-12-18 Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine Expired - Fee Related CA2812705C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US836507P 2007-12-19 2007-12-19
US836407P 2007-12-19 2007-12-19
US836307P 2007-12-19 2007-12-19
US61/008,363 2007-12-19
US61/008,364 2007-12-19
US61/008,365 2007-12-19
CA2747000A CA2747000C (fr) 2007-12-19 2008-12-18 Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2747000A Division CA2747000C (fr) 2007-12-19 2008-12-18 Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine

Publications (2)

Publication Number Publication Date
CA2812705A1 CA2812705A1 (fr) 2009-07-09
CA2812705C true CA2812705C (fr) 2015-08-18

Family

ID=40404919

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2812705A Expired - Fee Related CA2812705C (fr) 2007-12-19 2008-12-18 Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine
CA2747000A Expired - Fee Related CA2747000C (fr) 2007-12-19 2008-12-18 Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2747000A Expired - Fee Related CA2747000C (fr) 2007-12-19 2008-12-18 Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine

Country Status (4)

Country Link
AR (1) AR069867A1 (fr)
CA (2) CA2812705C (fr)
TW (1) TW200940543A (fr)
WO (1) WO2009085972A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8268832B2 (en) 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8269005B2 (en) 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8198278B2 (en) 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8212036B2 (en) 2007-12-19 2012-07-03 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8198277B2 (en) 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
MX2011007620A (es) 2009-01-16 2011-11-04 Exelixis Inc Sal de malato de n(4-{[6,7-bis(metiloxi)quinolin-4-il]oxi}fenil)-n '-(4-fluorofenil) ciclopropano-1,1-dicarboxamida, y sus formas cristalinas para el tratamiento de cancer.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
AU3245593A (en) * 1991-12-02 1993-06-28 Sepracor, Inc. Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
US5786357A (en) * 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
DK1691811T3 (da) * 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
WO2005063248A1 (fr) * 2003-12-22 2005-07-14 Sepracor Inc. Therapie combinatoire avec la modafinile pour ameliorer la qualite du sommeil
EP1732559B1 (fr) * 2004-04-05 2017-03-22 Sunovion Pharmaceuticals Inc. Procedes de traitement utilisant l'eszopiclone
WO2007006003A2 (fr) * 2005-07-06 2007-01-11 Sepracor Inc. Combinaisons d'eszopiclone et de trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphtalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphtalenamine, et methodes de traitement de la menopause et des troubles de l'humeur, de l'anxiete et troubles cognitifs

Also Published As

Publication number Publication date
WO2009085972A1 (fr) 2009-07-09
TW200940543A (en) 2009-10-01
CA2747000C (fr) 2013-09-03
AR069867A1 (es) 2010-02-24
CA2812705A1 (fr) 2009-07-09
CA2747000A1 (fr) 2009-07-09

Similar Documents

Publication Publication Date Title
US8889685B2 (en) Method for treating a sleep disorder with eszopiclone maleate
US8889686B2 (en) Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone
US8809332B2 (en) Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
US7456173B2 (en) Compositions comprising zopiclone derivatives and methods of making and using the same
US8269005B2 (en) L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8268832B2 (en) Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
EP1347979B1 (fr) Derives d'indole et leur utilisation en tant que ligands de recepteurs 5-ht2b et 5-ht2c
JP2023513680A (ja) 中枢神経系障害の治療のためのセロトニン作動性幻覚薬としてのシロシン誘導体
CA2812705C (fr) Sels de maleate, de besylate et de l-malate de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]-pyrazine
CA2747008C (fr) Sels de 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b] pyrazine
TW200811181A (en) Purinone derivatives as HM74a agonists
MXPA01011534A (es) Metodos de preparar y utilizar n-desmetilzopiclona.
PL165775B1 (pl) Sposób wytwarzania nowych aminokarbonylokarbaminianów PL PL PL PL
EP2981538B1 (fr) Pipérazino[1,2-a]indol-1-ones et [1,4]diazépino[1,2-a]indol-1-one
WO2026011223A1 (fr) Nouveaux sel et forme cristalline

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130412

MKLA Lapsed

Effective date: 20181218